UPDATE: Teva Withdraws Proposal to Acquire Mylan

Loading...
Loading...
Teva Pharmaceutical Industries Ltd.
TEVA
today announced that it has withdrawn its cash and stock proposal to acquire all of the outstanding ordinary shares of Mylan N.V.
MYL
and Teva does not intend to continue to pursue a transaction with Mylan at this time. Teva's decision to terminate the proposal to acquire Mylan follows today's announcement that Teva has entered into a definitive agreement with Allergan to acquire Allergan Generics. "In light of our strategic acquisition of Allergan Generics, which will transform the industry, our Board and management team has decided that withdrawing the proposal to acquire Mylan is in the best interests of Teva stockholders," said Erez Vigodman, President and CEO of Teva.
See full press release
Posted In: NewsM&APress Releases
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...